Related Experiment Videos
Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.
Gavin W Porter1, Fadlo R Khuri, Haian Fu
1Department of Pharmacology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. gporter@emory.edu
Seminars in Cancer Biology
|May 16, 2006
Summary
The 14-3-3 protein regulates apoptosis by interacting with various cellular proteins. Targeting 14-3-3 interactions offers a potential cancer therapy by inhibiting overactive survival pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The 14-3-3 protein family is a conserved group of serine/threonine binding proteins.
- 14-3-3 proteins interact with a wide range of client proteins, influencing numerous cellular processes.
- These proteins play a critical role in regulating apoptosis, the process of programmed cell death.
Purpose of the Study:
- To elucidate the multifaceted role of 14-3-3 proteins in apoptosis regulation.
- To explore the therapeutic potential of targeting 14-3-3 protein interactions in cancer treatment.
Main Methods:
- The study reviews existing literature on 14-3-3 protein interactions and their involvement in apoptosis.
- Analysis of signaling pathways and molecular mechanisms underlying 14-3-3 mediated apoptosis suppression and induction.
Main Results:
- 14-3-3 proteins inhibit apoptosis by sequestering pro-apoptotic client proteins and coordinating with survival kinases.
- Cellular stress can induce apoptosis by inhibiting 14-3-3 protein function.
- Global inhibition of 14-3-3/client protein interactions triggers apoptosis.
Conclusions:
- 14-3-3 proteins are key regulators of apoptosis, acting as crucial checkpoints in cell survival and death.
- Dysregulation of 14-3-3 proteins is linked to poor prognosis in cancer patients.
- Targeting 14-3-3 protein interactions presents a promising therapeutic strategy for cancers characterized by aberrant survival signaling.